MX9602559A - Nuevos derivados de piperidina con actividad antagonista del paf. - Google Patents
Nuevos derivados de piperidina con actividad antagonista del paf.Info
- Publication number
- MX9602559A MX9602559A MX9602559A MX9602559A MX9602559A MX 9602559 A MX9602559 A MX 9602559A MX 9602559 A MX9602559 A MX 9602559A MX 9602559 A MX9602559 A MX 9602559A MX 9602559 A MX9602559 A MX 9602559A
- Authority
- MX
- Mexico
- Prior art keywords
- antagonist activity
- piperidine derivatives
- paf antagonist
- novel piperidine
- paf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Los compuestos de formula general I y sus sales y solvatos son antagonistas de PAF y como tales son utiles en el tratamiento de diversas enfermedades o trastornos mediados por el PAF. Se describen también composiciones para su preparacion.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES09402291A ES2087038B1 (es) | 1994-11-07 | 1994-11-07 | Nuevas piperidinas con actividad antagonista del paf. |
ES9402291 | 1994-11-07 | ||
PCT/EP1995/003487 WO1996014317A1 (en) | 1994-11-07 | 1995-09-05 | Novel piperidine derivatives with paf antagonist activity |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9602559A true MX9602559A (es) | 1997-07-31 |
MXPA96002559A MXPA96002559A (es) | 1997-12-01 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
PT738269E (pt) | 2000-08-31 |
ES2147616T3 (es) | 2000-09-16 |
DE69516503T2 (de) | 2001-03-15 |
ATE192152T1 (de) | 2000-05-15 |
DE69516503D1 (de) | 2000-05-31 |
AU3563695A (en) | 1996-05-31 |
NO962855L (no) | 1996-07-05 |
NO962855D0 (no) | 1996-07-05 |
GR3033528T3 (en) | 2000-09-29 |
DK0738269T3 (da) | 2000-08-28 |
JPH09507862A (ja) | 1997-08-12 |
EP0738269A1 (en) | 1996-10-23 |
DK0738269T5 (da) | 2000-12-18 |
NO306345B1 (no) | 1999-10-25 |
WO1996014317A1 (en) | 1996-05-17 |
ES2087038A1 (es) | 1996-07-01 |
EP0738269B1 (en) | 2000-04-26 |
JP4018137B2 (ja) | 2007-12-05 |
US5705504A (en) | 1998-01-06 |
ES2087038B1 (es) | 1997-03-16 |
KR100514201B1 (ko) | 2005-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2087038A1 (es) | Nuevas piperidinas con actividad antagonista del paf. | |
NZ333801A (en) | Piperidine and piperazine derivatives and their use as muscarinic antagonists | |
MY112102A (en) | Therapeutic heterocycles. | |
PL308217A1 (en) | Derivatives of 1-(oxo-acetyl)-piperidine-2-carboxylic as agents sensibilising multiple-drug-resistant cancer cells | |
IL123002A0 (en) | 1-Phenyl-2- phenylacetoxy- ethanone derivatives | |
IL114894A (en) | Pyrrolidine derivatives as endothelin antagonists, pharmaceutical compositions containing them, and their use in the preparation of medicaments | |
IL117149A0 (en) | Muscarinic antagonists | |
ATE427936T1 (de) | Substituierte piperidin-verbindungen als modulatoren der chemokine receptor aktivitat | |
DE69715865D1 (de) | Muscarin-antagonisten | |
MX9702382A (es) | Nuevos derivados de pirimidona con actividad antifungica. | |
EP0896533A4 (en) | PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS | |
MX9704777A (es) | Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen. | |
ATE201671T1 (de) | Chinolon und acridinon derivate zur behandlung der harninkontinenz | |
GB9502644D0 (en) | Heterocyclic derivatives | |
GR3031215T3 (en) | Bicyclic heterocycles as neurokinin a antagonists | |
HK1018265A1 (en) | Piperazino derivatives as neurokinin antagonists | |
MX9708416A (es) | Derivados de piperazino como antagonistas de neuroquininas. | |
GR3032950T3 (en) | Substituted fused and bridged bicyclic compounds as therapeutic agents | |
BG105923A (en) | Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives | |
GB9116056D0 (en) | Compounds | |
CA2180660A1 (en) | Novel piperidine derivatives with paf antagonist activity | |
MX9703610A (es) | Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
PD | Change of proprietorship |
Owner name: PALAU PHARMA, S.A. |
|
MM | Annulment or lapse due to non-payment of fees |